Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi(Mayo Clinic in Arizona), Alessandro M. Vannucchi(University of Florence)
Cited by 722
Related Papers
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
|Leukemia|2013|666
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
|Blood Cancer Journal|2018|632
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
|Journal of Clinical Oncology|2011|586
Co‐targeting the PI3K/ <scp>mTOR</scp> and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
|Journal of Cellular and Molecular Medicine|2013|136